NEW DELHI, Jan 2 (Reuters) - Experts at India's drug
regulator have recommended emergency-use approval for the
AstraZeneca/Oxford vaccine and another developed locally by
Bharat Biotech and a state-run research body, the government
said on Saturday.
(Reporting by Krishna N. Das, Editing by William Maclean)
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)
Read more